Printer Friendly

SYBRON ANNOUNCES RECORD YEAR FOR SALES AND NET INCOME

 MILWAUKEE, Nov. 11 /PRNewswire/ -- Sybron Corporation (NYSE: SYB) today announced its financial results for the fourth quarter and full year ended Sept. 30, 1993.
 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
 Sybron Corporation had net income of $8.7 million for the fourth quarter of the current fiscal year before a restructuring charge of $2.5 million. The restructuring charge, as previously announced, related to the realignment of the company's two dental subsidiaries.
 For the year ended Sept. 30, 1993, the company had net income of $30.1 million before several one-time charges relating to a) the sale of the company's Brazilian operations in the first quarter, b) the bankruptcy of Healthco International Inc., a dental products distributor, in the third quarter, c) the extraordinary write-off of deferred financing and note premium as a result of the company's refinancing of its debt in the third quarter and d) the restructuring charge referred to above. The effects to net income were approximately $.5 million, $1.3 million, $8.5 million and $2.5 million, respectively.
 Net sales for the fourth quarter of fiscal 1993 totaled $100.9 million, compared to $100.1 million for the corresponding 1992 period, an increase of .7 percent. Excluding the foreign currency effects of $2.6 million and the 1992 sales from the company's Brazilian operation, the sales increase would have been 5.0 percent. For the 1993 year, net sales were $395.4 million, an increase of 3.3 percent. Had the dollar remained at the same level as the previous year and eliminating the Brazilian sales, the increase would have been 6.1 percent.
 Cash flow continues to be strong, as earnings before interest, taxes, depreciation and amortization (EBITDA) excluding the restructuring charge for the quarter was $28.4 million as compared with $26.7 million for the same quarter of 1992, an increase of 6.4 percent. EBITDA for 1993 was $110.8 million, up 10.4 percent from $100.4 million in the 1992 period. EBITDA in 1993 is prior to the sale of the Brazilian operations, the restructuring, Healthco and the extraordinary item.
 For comparative purposes, assuming the company's May 7, 1992, initial public offering had taken place on the first day of each of the 1993 and 1992 periods, net income before the restructuring would have been $.38 per share on a fully diluted pro forma basis for the fourth quarter of the current fiscal year, and $.32 for the like pro forma period of a year ago.
 For the 1993 fiscal year, excluding the sale of the Brazilian operations, Healthco, the restructuring and extraordinary item, net income would have been $1.33 per share on a fully diluted pro forma basis, up from $.98 per share for the like pro forma period of a year ago.
 Kenneth F. Yontz, chairman, president and chief executive officer, said that he was pleased with the company's operating results for the fourth quarter of fiscal 1993 which were on target with the company's expectations. After adjusting for currency and the sale of the company's Brazilian operations, foreign sales were up in real terms 8.7 percent and 6.7 percent for the quarter and for the year, respectively. Given this year's economic conditions overseas, Yontz stated this was an outstanding performance. The current year's gross and operating margins before the restructuring and Healthco also improved to 50.6 percent and 21.6 percent, respectively, from 49.6 percent and 19.4 percent, respectively, in the like period of a year ago, reflecting the effectiveness of tight cost controls in helping to offset the effects on the margins of a strengthened dollar and soft economic conditions around the world.
 On a separate note, the company announced that its board of directors has set Dec. 1, 1993 as the record date for determining shareholders entitled to vote at its annual meeting to be held on Jan. 19, 1994.
 Sybron Corporation's subsidiaries design, manufacture and market laboratory and dental supply products worldwide. Brands include Erie Scientific laboratory microscope slides, Nalge Company reusable and high value disposable plastic labware, Barnstead Thermolyne precision heating and stirring apparatus and water purification systems for laboratories, Ormco orthodontic products and Kerr dental materials.
 The company also reported the following results:
 SYBRON CORPORATION
 (Millions of dollars except earnings per share)
 Fourth Quarter
 9/30/93 9/30/92
 Net sales $100.9 $100.1
 Gross profit 51.7 51.3
 Selling, general & adm. expenses 29.7 30.8
 Restructuring charge 4.0 --
 Operating income 18.0 20.5
 Income before taxes 11.4 11.5
 Income taxes 5.2 4.4
 Net income $6.2 $7.1
 Earnings per share:
 Earnings per share $.27 $.32
 Pro forma earnings per share
 before restructuring $.38 $.32
 Year ended
 9/30/93 9/30/92
 Net sales $395.4 $382.6
 Gross profit 199.9 189.9
 Selling, general & adm. expenses 116.6 115.6
 Restructuring charge 4.0 --
 Operating income 79.4 74.3
 Income before taxes and
 extraordinary item 46.2 36.0
 Income taxes 20.5 14.6
 Net income before extraordinary item 25.8 21.4
 Extraordinary item (8.5) --
 Net income $17.3 $21.4
 Earnings per share:
 Earnings before extraordinary item 1.13 .61
 Extraordinary item (.37) --
 Earnings per share .76 .61
 Pro forma earnings per share prior to
 sale of Brazilian operations,
 restructuring, Healthco and
 extraordinary item $1.33 $.98
 -0- 11/11/93
 /CONTACT: Dennis Brown, of Sybron Corporation, 414-274-6600; or John Ochotnicky, of Hoffman York & Compton, 414-289-9700/
 (SYB) CO: Sybron Corporation ST: Wisconsin IN: MTC SU: ERN


CP-KH -- MN020 -- 3372 11/11/93 16:18 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 11, 1993
Words:940
Previous Article:LODGENET ENTERTAINMENT CORPORATION REPORTS THIRD QUARTER EARNINGS
Next Article:XATA CORPORATION REPORTS FOURTH QUARTER AND ANNUAL RESULTS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters